Sartorius Stedim Biotech S.A.

ENXTPA:DIM Voorraadrapport

Marktkapitalisatie: €16.3b

Sartorius Stedim Biotech Toekomstige groei

Future criteriumcontroles 4/6

Sartorius Stedim Biotech zal naar verwachting groeien in winst en omzet met respectievelijk 31.9% en 10.4% per jaar. De winst per aandeel zal naar verwachting groeien met 31.9% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 13.7% zijn.

Belangrijke informatie

31.9%

Groei van de winst

31.9%

Groei van de winst per aandeel

Life Sciences winstgroei26.3%
Inkomstengroei10.4%
Toekomstig rendement op eigen vermogen13.7%
Dekking van analisten

Good

Laatst bijgewerkt18 Nov 2024

Recente toekomstige groei-updates

Sartorius Stedim Biotech S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Jul 21
Sartorius Stedim Biotech S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Sartorius Stedim Biotech S.A. Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next

Apr 21
Sartorius Stedim Biotech S.A. Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next

Recent updates

Sartorius Stedim Biotech's (EPA:DIM) Weak Earnings May Only Reveal A Part Of The Whole Picture

Oct 25
Sartorius Stedim Biotech's (EPA:DIM) Weak Earnings May Only Reveal A Part Of The Whole Picture

Sartorius Stedim Biotech S.A.'s (EPA:DIM) Share Price Not Quite Adding Up

Oct 15
Sartorius Stedim Biotech S.A.'s (EPA:DIM) Share Price Not Quite Adding Up

Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Aug 11
Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Sartorius Stedim Biotech S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Jul 21
Sartorius Stedim Biotech S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)

Jul 12
Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)

Sartorius Stedim Biotech (EPA:DIM) Has A Somewhat Strained Balance Sheet

May 13
Sartorius Stedim Biotech (EPA:DIM) Has A Somewhat Strained Balance Sheet

Sartorius Stedim Biotech S.A. Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next

Apr 21
Sartorius Stedim Biotech S.A. Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next

With A 26% Price Drop For Sartorius Stedim Biotech S.A. (EPA:DIM) You'll Still Get What You Pay For

Apr 20
With A 26% Price Drop For Sartorius Stedim Biotech S.A. (EPA:DIM) You'll Still Get What You Pay For

Weak Statutory Earnings May Not Tell The Whole Story For Sartorius Stedim Biotech (EPA:DIM)

Feb 19
Weak Statutory Earnings May Not Tell The Whole Story For Sartorius Stedim Biotech (EPA:DIM)

Sartorius Stedim Biotech S.A.'s (EPA:DIM) Popularity With Investors Is Clear

Dec 22
Sartorius Stedim Biotech S.A.'s (EPA:DIM) Popularity With Investors Is Clear

Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?

Dec 01
Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?

Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?

Nov 10
Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?

Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Aug 23
Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Sartorius Stedim Biotech (EPA:DIM) Seems To Use Debt Quite Sensibly

May 25
Sartorius Stedim Biotech (EPA:DIM) Seems To Use Debt Quite Sensibly

Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Is Well Worth Watching

May 09
Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Is Well Worth Watching

Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?

Apr 23
Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?

Here's Why Sartorius Stedim Biotech (EPA:DIM) Can Manage Its Debt Responsibly

Feb 07
Here's Why Sartorius Stedim Biotech (EPA:DIM) Can Manage Its Debt Responsibly

Does Sartorius Stedim Biotech (EPA:DIM) Deserve A Spot On Your Watchlist?

Jan 20
Does Sartorius Stedim Biotech (EPA:DIM) Deserve A Spot On Your Watchlist?

Sartorius Stedim Biotech (EPA:DIM) Has A Pretty Healthy Balance Sheet

Nov 09
Sartorius Stedim Biotech (EPA:DIM) Has A Pretty Healthy Balance Sheet

Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Might Deserve Your Attention Today

Oct 20
Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Might Deserve Your Attention Today

Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)

Oct 03
Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)

We Think Sartorius Stedim Biotech (EPA:DIM) Can Stay On Top Of Its Debt

Jul 26
We Think Sartorius Stedim Biotech (EPA:DIM) Can Stay On Top Of Its Debt

Do Sartorius Stedim Biotech's (EPA:DIM) Earnings Warrant Your Attention?

Jul 09
Do Sartorius Stedim Biotech's (EPA:DIM) Earnings Warrant Your Attention?

Is Sartorius Stedim Biotech S.A. (EPA:DIM) Expensive For A Reason? A Look At Its Intrinsic Value

Jun 21
Is Sartorius Stedim Biotech S.A. (EPA:DIM) Expensive For A Reason? A Look At Its Intrinsic Value

Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt

Apr 21
Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt

Here's Why I Think Sartorius Stedim Biotech (EPA:DIM) Is An Interesting Stock

Apr 03
Here's Why I Think Sartorius Stedim Biotech (EPA:DIM) Is An Interesting Stock

We Like Sartorius Stedim Biotech's (EPA:DIM) Earnings For More Than Just Statutory Profit

Feb 24
We Like Sartorius Stedim Biotech's (EPA:DIM) Earnings For More Than Just Statutory Profit

Winst- en omzetgroeiprognoses

ENXTPA:DIM - Toekomstschattingen van analisten en financiële gegevens uit het verleden (EUR Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20263,35744741084012
12/31/20253,00334033374812
12/31/20242,76621230367213
9/30/20242,736161504866N/A
6/30/20242,747170305706N/A
3/31/20242,716255169636N/A
12/31/20232,776310273746N/A
9/30/20232,959460113625N/A
6/30/20233,170635162675N/A
3/31/20233,356717137606N/A
12/31/20223,493876182612N/A
9/30/20223,381681125552N/A
6/30/20223,259625193584N/A
3/31/20223,094559322661N/A
12/31/20212,887414378702N/A
9/30/20212,639523355623N/A
6/30/20212,393469367590N/A
3/31/20212,143398310506N/A
12/31/20201,910336258417N/A
9/30/20201,743299299414N/A
6/30/20201,600255243365N/A
3/31/20201,520254216345N/A
12/31/20191,441235174310N/A
9/30/20191,393247142291N/A
6/30/20191,33623821261N/A
3/31/20191,27422388270N/A
12/31/20181,21220851227N/A
9/30/20181,17218557226N/A
6/30/20181,121173N/A225N/A
3/31/20181,093162N/A196N/A
12/31/20171,081161N/A175N/A
9/30/20171,073151N/A165N/A
6/30/20171,089157N/A169N/A
3/31/20171,075157N/A146N/A
12/31/20161,052154N/A157N/A
9/30/20161,009145N/A146N/A
6/30/2016971142N/A129N/A
3/31/2016926136N/A155N/A
12/31/2015884118N/A143N/A
9/30/2015850111N/A150N/A
6/30/201578189N/A128N/A
3/31/201573476N/A113N/A
12/31/201468472N/A111N/A
9/30/201464671N/A93N/A
6/30/201462067N/A110N/A
3/31/201460468N/A97N/A
12/31/201358866N/A90N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei DIM ( 31.9% per jaar) ligt boven de spaarquote ( 1.4% ).

Winst versus markt: De winst van DIM ( 31.9% per jaar) zal naar verwachting sneller groeien dan de French markt ( 12.5% per jaar).

Hoge groeiwinsten: De winst van DIM zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van DIM ( 10.4% per jaar) zal naar verwachting sneller groeien dan de markt French ( 5.6% per jaar).

Hoge groei-inkomsten: De omzet van DIM ( 10.4% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen DIM zal naar verwachting over 3 jaar laag zijn ( 13.7 %).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y